About Genext Genomics Private Limited
Data last updated:
Genext Genomics Private Limited is a private limited company based in Nagpur, Maharashtra, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 24 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U73100MH2011PTC212683. Its GSTIN is 27AAECG1477C1ZT (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Supriya Kashikar (Whole-Time Director) and Manjiri Sandeep Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 Abhyankar Nagar Zenda Chowk, Nagpur, Maharashtra, India – 440010.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.16 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net loss of ₹2.68 Cr (net margin -405.8%) and EBITDA of -₹1.99 Cr (EBITDA margin -301%). Revenue has grown at a compounded annual rate (CAGR) of 322% over three years and 55% over five years.
The company is associated with 1 brand: GeNext Genomics.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genextgenomics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address103 Abhyankar Nagar Zenda Chowk, Nagpur, Maharashtra, India – 440010
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Genext Genomics Private Limited
The main business activity of Genext Genomics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Genext Genomics Private Limited FY 2025 filings available
Genext Genomics Private Limited reported revenue of ₹66.16 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Genext Genomics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 10% growth in the latest year. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genext Genomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.99 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.68 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genext Genomics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -301% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -405.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genext Genomics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Genext Genomics Private Limited
Genext Genomics Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology, Genomics). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Miraee Biotech Private Limited | ₹66.9 Lakh (FY 2025) | •••• | •••• | 287.0% | •••• | Hyderabad, Telangana, India |
| Fermentech GSV Private Limited | ₹66.46 Lakh (FY 2024) | •••• | •••• | 203.0% | •••• | Thanjavur, Tamil Nadu, India |
| Nanosafe Solutions Private Limited | ₹66.38 Lakh (FY 2024) | •••• | •••• | 37.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| VGBL Ventures (India) Limited | ₹66.25 Lakh (FY 2020) | •••• | •••• | 5.0% | •••• | Miraj, Maharashtra, India |
| Cambrian Biotech Private Limited | ₹66.2 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Genext Genomics Private Limited this company | ₹66.16 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Nagpur, Maharashtra, India |
| Sun Agro Biosystem Private Limited | ₹65.66 Lakh (FY 2020) | •••• | •••• | -23.0% | •••• | Chennai, Tamil Nadu, India |
| Growdea Technologies Private Limited | ₹65.51 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Gurugram, Haryana, India |
| Eukpro Biotech Private Limited | ₹65.1 Lakh (FY 2021) | •••• | •••• | -30.0% | •••• | Kancheepuram, Tamil Nadu, India |
| Fatherson Biotech Private Limited | ₹64.25 Lakh (FY 2024) | •••• | •••• | 898833.0% | •••• | Delhi, India |
| Vepco Bio-Tech Private Limited | ₹61.04 Lakh (FY 2025) | •••• | •••• | 868.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Genext Genomics by revenue in the Biotechnology industry (Biotechnology, Genomics), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Genext Genomics Private Limited
Genext Genomics Private Limited is audited by RODI DABIR & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RODI DABIR & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Genext Genomics Private Limited
Genext Genomics has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjiri Sandeep Singh Also directs: Dharti Farming and Cultivation Private Limited, Anantha Seeds Private Limited, Dharti Agro Chemicals Private Limited and 1 more | Director | 24 Jan 2011 | 15 Years 8 Months | Current |
| Supriya Kashikar | Whole-Time Director | 16 Feb 2018 | 8 Years 7 Months | Current |
| Ashwin Ravi Kashikar | Director | 24 Jan 2011 | 15 Years 8 Months | Current |
| Shivali Vaibhav Kashikar | Director | 24 Jan 2011 | 15 Years 8 Months | Current |
| Ravi Madan Kashikar | Director | 24 Jan 2011 | 15 Years 8 Months | Current |
Ownership and Shareholding of Genext Genomics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genext Genomics Private Limited
Genext Genomics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Genext Genomics Private Limited
Genext Genomics operates one associated brand: GeNext Genomics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Recombinant proteins and monoclonal antibodies are developed for life sciences. | genextgenomics.com |
Employees and EPFO Compliance at Genext Genomics Private Limited
Employment history and EPFO contributions of people linked to Genext Genomics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Genext Genomics Private Limited
Genext Genomics Private Limited has 5 board changes on record since 2011: 5 appointments. The latest: Supriya Kashikar was appointed as Whole-Time Director on 16 Feb 2018.
Credit Ratings, Litigation & Regulatory Alerts for Genext Genomics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genext Genomics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genext Genomics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Genext Genomics Private Limited
Genext Genomics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECG1477C1ZT | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genext Genomics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genext Genomics Private Limited
Genext Genomics is an active private limited company based in Nagpur, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 24 January 2011 (15+ years old) and is registered under CIN U73100MH2011PTC212683.
Genext Genomics reported revenue of ₹66.16 Lakh for FY 2025 (up 10% YoY).
Genext Genomics has 5 current directors:
- Supriya Kashikar - Whole-Time Director
- Manjiri Sandeep Singh - Director
- Ashwin Ravi Kashikar - Director
- Shivali Vaibhav Kashikar - Director
- Ravi Madan Kashikar - Director
Genext Genomics reported a net loss of ₹2.68 Cr (net margin -405.8%) and EBITDA of -₹1.99 Cr (EBITDA margin -301%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genext Genomics is 322% over three years and 55% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Genext Genomics is 27AAECG1477C1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Genext Genomics is U73100MH2011PTC212683. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genext Genomics was incorporated on 24 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Genext Genomics by revenue are Miraee Biotech Private Limited, Fermentech GSV Private Limited, Nanosafe Solutions Private Limited, VGBL Ventures (India) Limited, Cambrian Biotech Private Limited and 5 more, all in the Biotechnology industry (Biotechnology, Genomics).
Supriya Kashikar was appointed as Whole-Time Director on 16 Feb 2018. Ashwin Ravi Kashikar was appointed as Director on 24 Jan 2011. Manjiri Sandeep Singh was appointed as Director on 24 Jan 2011. Genext Genomics has 5 board changes on record in total.
Yes, Genext Genomics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).